Katsuya Y[au] - Search Results

Year	Number of Results
1985	1
1992	1
1996	1
1998	2
2000	3
2001	9
2002	3
2004	1
2005	1
2006	2
2007	4
2008	1
2010	1
2011	1
2012	2
2014	4
2015	9
2016	4
2017	1
2018	5
2019	10
2020	1
2022	4
2023	7
2024	5

1

Immunologic Significance of CD80/CD86 or Major Histocompatibility Complex-II Expression in Thymic Epithelial Tumors.

Ikeda H, Nagasaki J, Shimizu D, Katsuya Y, Horinouchi H, Hosomi Y, Tanji E, Iwata T, Itami M, Kawazu M, Ohe Y, Suzuki T, Togashi Y. Ikeda H, et al. Among authors: katsuya y. JTO Clin Res Rep. 2023 Sep 9;4(10):100573. doi: 10.1016/j.jtocrr.2023.100573. eCollection 2023 Oct. JTO Clin Res Rep. 2023. PMID: 37799325 Free PMC article.

2

Travel Time and Distance and Participation in Precision Oncology Trials at the National Cancer Center Hospital.

Uehara Y, Koyama T, Katsuya Y, Sato J, Sudo K, Kondo S, Yoshida T, Shoji H, Shimoi T, Yonemori K, Yamamoto N. Uehara Y, et al. Among authors: katsuya y. JAMA Netw Open. 2023 Sep 5;6(9):e2333188. doi: 10.1001/jamanetworkopen.2023.33188. JAMA Netw Open. 2023. PMID: 37713200 Free PMC article.

3

Current and future trends in whole genome sequencing in cancer.

Katsuya Y. Katsuya Y. Cancer Biol Med. 2024 Feb 15;21(1):16-20. doi: 10.20892/j.issn.2095-3941.2023.0420. Cancer Biol Med. 2024. PMID: 38356245 Free PMC article. Review. No abstract available.

4

Emerging PD-1/PD-L1 targeting immunotherapy in non-small cell lung cancer: Current status and future perspective in Japan, US, EU, and China.

Mizuno T, Katsuya Y, Sato J, Koyama T, Shimizu T, Yamamoto N. Mizuno T, et al. Among authors: katsuya y. Front Oncol. 2022 Aug 26;12:925938. doi: 10.3389/fonc.2022.925938. eCollection 2022. Front Oncol. 2022. PMID: 36091105 Free PMC article. Review.

5

Phase Ib/II Study of a Liposomal Formulation of Eribulin (E7389-LF) plus Nivolumab in Patients with Advanced Solid Tumors: Results from Phase Ib.

Ida H, Shimizu T, Nishino M, Nakamura Y, Yazaki S, Katsuya Y, Sato J, Koyama T, Iwasa S, Sudo K, Kondo S, Yonemori K, Shitara K, Shiono S, Matsuoka D, Yasuda K, Otake Y, Suzuki T, Takase T, Takashima S, Yamaguchi K, Semba T, Yamamoto N. Ida H, et al. Among authors: katsuya y. Cancer Res Commun. 2023 Jul 10;3(7):1189-1199. doi: 10.1158/2767-9764.CRC-22-0401. eCollection 2023 Jul. Cancer Res Commun. 2023. PMID: 37435605 Free PMC article. Clinical Trial.

6

Correlation of toxicities and efficacies of pemetrexed with clinical factors and single-nucleotide polymorphisms: a prospective observational study.

Takeda Y, Naka G, Katsuya Y, Kobayashi K, Suzuki M, Hashimoto M, Hirano S, Uemura Y. Takeda Y, et al. Among authors: katsuya y. BMC Cancer. 2023 Aug 26;23(1):800. doi: 10.1186/s12885-023-11257-8. BMC Cancer. 2023. PMID: 37633908 Free PMC article.

7

Pathogenic Germline Variants in BRCA1/2 and p53 Identified by Real-world Comprehensive Cancer Genome Profiling Tests in Asian Patients.

Satake T, Kondo S, Tanabe N, Mizuno T, Katsuya Y, Sato J, Koyama T, Yoshida T, Hirata M, Yamamoto N. Satake T, et al. Among authors: katsuya y. Cancer Res Commun. 2023 Nov 14;3(11):2302-2311. doi: 10.1158/2767-9764.CRC-23-0018. Cancer Res Commun. 2023. PMID: 37916805 Free PMC article.

8

Practical consideration for successful sequential tumor biopsies in first-in-human trials.

Koyama T, Shimizu T, Sato J, Katsuya Y, Iwasa S, Kondo S, Yoshida T, Sudo K, Nishino M, Takiguchi Y, Yonemori K, Yamamoto N. Koyama T, et al. Among authors: katsuya y. Invest New Drugs. 2022 Aug;40(4):841-849. doi: 10.1007/s10637-022-01236-4. Epub 2022 Apr 11. Invest New Drugs. 2022. PMID: 35404018 Free PMC article.

9

Ocular toxicity of investigational anti-cancer drugs in early phase clinical trials.

Takamizawa S, Katsuya Y, Chen YN, Mizuno T, Koyama T, Sudo K, Yoshida T, Kondo S, Iwasa S, Yonemori K, Shimizu T, Yamamoto N, Suzuki S. Takamizawa S, et al. Among authors: katsuya y. Invest New Drugs. 2023 Feb;41(1):173-181. doi: 10.1007/s10637-022-01321-8. Epub 2022 Dec 5. Invest New Drugs. 2023. PMID: 36471215 Free PMC article. Clinical Trial.

10

NUT midline carcinoma of the mediastinum showing two types of poorly differentiated tumor cells: a case report and a literature review.

Nakamura H, Tsuta K, Tsuda H, Katsuya Y, Naka G, Iizuka T, Igari T. Nakamura H, et al. Among authors: katsuya y. Pathol Res Pract. 2015 Jan;211(1):92-8. doi: 10.1016/j.prp.2014.07.006. Epub 2014 Jul 22. Pathol Res Pract. 2015. PMID: 25433996 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Results by year